Pharmacy

International Drug Discovery and Clinical Research (IDDCR)  and the prestigious Temple University's School of Pharmacy  (TUSP), US, have joined hands in the delivery of global  certificate programmes to India. Starting in late August Clinical ReseatCti    

IDDCR will bring Temple University s globally recognized Quality Assurance/Regulatory Affairs (QA/RA) graduate programme to students in Hyderabad, offering one-year Post Graduate Diploma Programmes that cover key concept? in the pharmaceutical industry. IDDCR intends to educate 80-100 select students in clinical trial management and global pharmacovigilance each year. The certificate programmes will help ease the demand for high-quality clinical trial and pharmacovigilance professionals from big pharma, start up, generic drug, biotechnology, and clinical research organizations in India. Founded in 1884 in Philadelphia, PA, Temple University is the sixth largest provider of professional education in the US, and its QA/RA graduate programme is the oldest and most comprehensive of its type in the world. IDDCR provides practical training and resources for global biotech and pharmaceutical companies Vamsi Maddipatia, CEO, IDDCR, said, "various centres and institutions current!} Offer certification, but this initiative by IDDCR-Temple creates the only fully industry- focused certificate programme in clinical trials and pharmacovigilance in India."